ALLOGENEIC TCRA/CD38 DOUBLE KNOCKOUT T-CELLS BEARING AN ANTI-CD38 CHIMERIC ANTIGEN RECEPTOR: AN IMPROVED IMMUNOTHERAPY FOR THE TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND MULTIPLE MYELOMA

被引：0
|
作者：
Dusseaux, M. [1 ]
Le Clerre, D. [1 ]
Gouble, A. [1 ]
Smith, J. [1 ]
机构：
[1] Cellectis, Paris, France
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P365
引用
收藏
页码：122 / 123
页数：2
相关论文
共 50 条
  • [1] T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells
    Mihara, K.
    Bhattacharyya, J.
    Kitanaka, A.
    Yanagihara, K.
    Kubo, T.
    Takei, Y.
    Asaoku, H.
    Takihara, Y.
    Kimura, A.
    LEUKEMIA, 2012, 26 (02) : 365 - 367
  • [2] T-Cell Immunotherapy with a Chimeric Receptor Against CD38 Is Effective in Eliminating Myeloma Cells
    Mihara, Keichiro
    Bhattacharyya, Joyeeta
    Kitanaka, Akira
    Ihara, Akihiro
    Sakai, Akira
    Kuroda, Yoshiaki
    Asaoku, Hideki
    Takihara, Yoshihiro
    Kimura, Akiro
    BLOOD, 2011, 118 (21) : 405 - 405
  • [3] T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells
    K Mihara
    J Bhattacharyya
    A Kitanaka
    K Yanagihara
    T Kubo
    Y Takei
    H Asaoku
    Y Takihara
    A Kimura
    Leukemia, 2012, 26 : 365 - 367
  • [4] CD38 Chimeric Antigen Receptor Engineered T Cells As Therapeutic Tools for Multiple Myeloma
    Drent, Esther
    Groen, Richard
    Noort, Willy A.
    van Bueren, Jeroen Lammerts
    Parren, Paul W. H. I.
    Kuball, Jurgen H.
    Sebestyen, Zsolt
    van de Donk, Niels W. C. J.
    Martens, Anton C.
    Lokhorst, Henk M.
    Mutis, Tuna
    BLOOD, 2014, 124 (21)
  • [5] All-trans retinoic acid and interferon-α increase CD38 expression on adult T-cell leukemia cells and sensitize them to T cells bearing anti-CD38 chimeric antigen receptors
    Mihara, K.
    Yoshida, T.
    Ishida, S.
    Takei, Y.
    Kitanaka, A.
    Shimoda, K.
    Morishita, K.
    Takihara, Y.
    Ichinohe, T.
    BLOOD CANCER JOURNAL, 2016, 6 : e421 - e421
  • [6] All-trans retinoic acid and interferon-α increase CD38 expression on adult T-cell leukemia cells and sensitize them to T cells bearing anti-CD38 chimeric antigen receptors
    K Mihara
    T Yoshida
    S Ishida
    Y Takei
    A Kitanaka
    K Shimoda
    K Morishita
    Y Takihara
    T Ichinohe
    Blood Cancer Journal, 2016, 6 : e421 - e421
  • [7] Anti-Multiple Myeloma Activity of Nanobody-Based Anti-CD38 Chimeric Antigen Receptor T Cells
    An, Na
    Hou, Yun Nan
    Zhang, Qiao Xia
    Li, Ting
    Zhang, Qiong Li
    Fang, Cheng
    Chen, Huan
    Lee, Hon Cheung
    Zhao, Yong Juan
    Du, Xin
    MOLECULAR PHARMACEUTICS, 2018, 15 (10) : 4577 - 4588
  • [8] Targetting CD38 in T Cell Acute Lymphoblastic Leukemia
    Bride, Karen L.
    Vincent, Tiffaney L.
    Im, Soo-Yeon
    Barrett, David M.
    Hermiston, Michelle L.
    Horton, Terzah M.
    Loh, Mignon L.
    Maude, Shannon L.
    Grupp, Stephan A.
    Wood, Brent
    Teachey, David T.
    BLOOD, 2017, 130
  • [9] Allogenic TCRa/CS1 double knockout T-cells bearing an anti-CS1 chimeric antigen receptor: An improved immunotherapy approach for the treatment of multiple myeloma
    Galetto, Roman
    Chion-Sotinel, Isabelle
    Gouble, Agnes
    Smith, Julianne
    CANCER RESEARCH, 2016, 76
  • [10] All-Trans Retinoic Acid and Interferon-Alpha Increase CD38 Expression on Adult T-Cell Leukemia Cells and Sensitize Them to T Cells Bearing Anti-CD38 Chimeric Antigen Receptors
    Mihara, Keichiro
    Yoshida, Tetsumi
    Ishida, Seiko
    Takei, Yoshifumi
    Kitanaka, Akira
    Shimoda, Kazuya
    Morishita, Kazuhiro
    Takihara, Yoshihiro
    Ichinohe, Tatsuo
    BLOOD, 2015, 126 (23)
12345